6533b823fe1ef96bd127ed44
RESEARCH PRODUCT
The future of Extracellular Vesicles as Theranostics – an ISEV meeting report
Qian WangBo LiJing ChenHarry HolthöferFuquan YangXiaomei YanXue ZouAna Claudia TorrecilhasFaezeh ShekariHaifang WangLesley CheungYu XiaoWeilun PanLei ZhengMinh T.n. LeAntonio MarcillaLorraine O'driscollHang YinYong Song GhoJuan M. Falcón-pérezZezhou ZhaoTaixue AnYiyao HuangYiyao HuangCarolina SoekmadjiCarolina SoekmadjiChunchen LiuTang-long Shensubject
0301 basic medicineEngineeringHistologytheranosticMeeting ReportFreeze thawingExtracellular vesiclesCa 19 9 antigen03 medical and health sciences0302 clinical medicineClinical investigationIn vitro studylcsh:QH573-671therapylcsh:Cytologybusiness.industryDietary intakeAntibody affinityCell BiologyExtracellular vesicles030104 developmental biology030220 oncology & carcinogenesisAntisense oligonucleotidesbiomarkerEngineering ethicsbusinessdescription
ABSTRACT The utilization of extracellular vesicles (EVs) in clinical theranostics has rapidly advanced in the past decade. In November 2018, the International Society for Extracellular Vesicles (ISEV) held a workshop on “EVs in Clinical Theranostic”. Here, we report the conclusions of roundtable discussions on the current advancement in the analysis technologies and we provide some guidelines to researchers in the field to consider the use of EVs in clinical application. The main challenges and the requirements for EV separation and characterization strategies, quality control and clinical investigation were discussed to promote the application of EVs in future clinical studies.
year | journal | country | edition | language |
---|---|---|---|---|
2020-01-01 | Journal of Extracellular Vesicles |